(Q45002702)

English

Assessing the health and economic impact of galantamine treatment in patients with Alzheimer's disease in the health care systems of different countries

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Assessing the health and economic impact of galantamine treatment in patients with Alzheimer's disease in the health care systems of different countries (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Alzheimer's disease

0 references

1

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

author name string

Maribel Salas

2

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Alexandra Ward

3

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Denis Getsios

4

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Kristen Migliaccio-Walle

5

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Frances Garfield

6

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

publication date

1 January 2004

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

21

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

677-686

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

https://scigraph.springernature.com/pub.10.2165/00002512-200421100-00005

0 references

Cost of illness due to dementia in Sweden

1 reference

https://pubmed.ncbi.nlm.nih.gov/15287825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Care services for dementia patients: predictors for service utilization.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15287825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relation between severity of Alzheimer's disease and costs of caring

1 reference

https://pubmed.ncbi.nlm.nih.gov/15287825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Economic analysis of galantamine, a cholinesterase inhibitor, in the treatment of patients with mild to moderate Alzheimer's disease in the Netherlands

1 reference

https://pubmed.ncbi.nlm.nih.gov/15287825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A 5-month, randomized, placebo-controlled trial of galantamine in AD. The Galantamine USA-10 Study Group.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15287825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Deinstitutionalization of the elderly in Finland, 1981-91.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15287825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/15287825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessment of health economics in Alzheimer's disease (AHEAD): galantamine treatment in Canada

1 reference

https://pubmed.ncbi.nlm.nih.gov/15287825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessment of health economics in Alzheimer's disease (AHEAD): treatment with galantamine in the UK.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15287825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/15287825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessment of health economics in Alzheimer's disease (AHEAD) based on need for full-time care.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15287825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevalence, costs, and treatment of Alzheimer's disease and related dementia: a managed care perspective.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15287825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Alzheimer's disease. The unpaid burden of caring

1 reference

https://pubmed.ncbi.nlm.nih.gov/15287825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The cost of treatment of Alzheimer's disease in The Netherlands: a regression-based simulation model.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15287825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessment of Health Economics in Alzheimer's Disease (AHEAD): treatment with galantamine in Sweden

1 reference

https://pubmed.ncbi.nlm.nih.gov/15287825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The economic burden of Alzheimer's disease care

1 reference

https://pubmed.ncbi.nlm.nih.gov/15287825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Galantamine for Alzheimer's disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15287825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predicting time to nursing home care and death in individuals with Alzheimer disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15287825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Prevalence of Dementia in Europe: A Collaborative Study of 1980–1990 Findings

1 reference

https://pubmed.ncbi.nlm.nih.gov/15287825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Group-living care: an alternative for the demented elderly.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15287825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Care dependency and survival among female patients with Alzheimer's disease: a two-year follow-up

1 reference

https://pubmed.ncbi.nlm.nih.gov/15287825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost-utility analysis of group living in dementia care

1 reference

https://pubmed.ncbi.nlm.nih.gov/15287825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dementia in old age and the need for services

1 reference

https://pubmed.ncbi.nlm.nih.gov/15287825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The demented elderly in the city of Helsinki: functional capacity and placement

1 reference

https://pubmed.ncbi.nlm.nih.gov/15287825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Health utilities in Alzheimer's disease: a cross-sectional study of patients and caregivers

1 reference

https://pubmed.ncbi.nlm.nih.gov/15287825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Survival of outpatients with Alzheimer-type dementia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15287825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The epidemic of Alzheimer's disease. How can we manage the costs?

1 reference

https://pubmed.ncbi.nlm.nih.gov/15287825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Galantamine provides sustained benefits in patients with 'advanced moderate' Alzheimer's disease for at least 12 months

1 reference

https://pubmed.ncbi.nlm.nih.gov/15287825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of Alzheimer disease with tacrine: a cost-analysis model.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15287825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessing the societal impact of acetylcholinesterase inhibitor therapies

1 reference

https://pubmed.ncbi.nlm.nih.gov/15287825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cholinesterase inhibitor treatment alters the natural history of Alzheimer's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/15287825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Galantamine in AD: A 6-month randomized, placebo-controlled trial with a 6-month extension. The Galantamine USA-1 Study Group.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15287825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevalence of severe dementia in Finland

1 reference

https://pubmed.ncbi.nlm.nih.gov/15287825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Worldwide prevalence and incidence of dementia

1 reference

https://pubmed.ncbi.nlm.nih.gov/15287825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

To what degree does cognitive impairment in Alzheimer's disease predict dependence of patients on caregivers?

1 reference

https://pubmed.ncbi.nlm.nih.gov/15287825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Costs of dementia and dementia care: a review

1 reference

https://pubmed.ncbi.nlm.nih.gov/15287825

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/00002512-200421100-00005

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45002702&oldid=2061585840"